A detailed history of Frisch Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 4,112 shares of BMY stock, worth $237,509. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,112
Holding current value
$237,509
% of portfolio
0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $163,081 - $212,796
4,112 New
4,112 $213,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $189,377 - $214,716
3,947 New
3,947 $214,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $97,313 - $108,811
-1,681 Reduced 20.27%
6,611 $384,000
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $528,283 - $586,576
8,292 New
8,292 $530,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $4,314 - $5,108
63 Added 0.66%
9,671 $696,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $8 - $4,994
65 Added 0.68%
9,608 $683,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $3,050 - $3,359
42 Added 0.44%
9,543 $735,000
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $24,161 - $28,971
-393 Reduced 3.97%
9,501 $694,000
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $11,744 - $13,691
219 Added 2.26%
9,894 $616,000
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $572,469 - $670,574
9,675 New
9,675 $572,000
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $584,954 - $685,198
-9,886 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $3,714 - $4,045
60 Added 0.61%
9,886 $661,000
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $24,151 - $27,163
407 Added 4.32%
9,826 $620,000
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $3,291 - $3,729
-57 Reduced 0.6%
9,419 $584,000
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $18,205 - $20,173
-317 Reduced 3.24%
9,476 $571,000
Q2 2020

Aug 06, 2020

SELL
$54.82 - $64.09 $6,030 - $7,049
-110 Reduced 1.11%
9,793 $576,000
Q1 2020

May 08, 2020

SELL
$46.4 - $67.43 $37,259 - $54,146
-803 Reduced 7.5%
9,903 $552,000
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $1,476 - $1,925
30 Added 0.28%
10,706 $687,000
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $39,733 - $47,109
929 Added 9.53%
10,676 $541,000
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $262,722 - $290,513
-5,888 Reduced 37.66%
9,747 $442,000
Q1 2019

May 06, 2019

BUY
$45.12 - $53.8 $992 - $1,183
22 Added 0.14%
15,635 $746,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $761,289 - $987,209
15,613 New
15,613 $812,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Frisch Financial Group, Inc. Portfolio

Follow Frisch Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.